Last reviewed · How we verify
Ethallymal (etallobarbital)
Ethallymal (generic name: etallobarbital) is a etallobarbital drug. It is currently in unknown development.
Etallobarbital works by enhancing the activity of a neurotransmitter called gamma-aminobutyric acid (GABA), which helps to calm the brain and nervous system.
Etallobarbital is a small molecule barbiturate with unknown target and pharmacological properties. Its commercial status is unclear, and it is not FDA-approved for any indications. As a barbiturate, etallobarbital is a central nervous system depressant, but its specific mechanism of action and safety profile are not well-documented. Further research is needed to fully understand its therapeutic potential and risks. Due to the lack of information, etallobarbital is not a widely recognized or used medication.
At a glance
| Generic name | etallobarbital |
|---|---|
| Drug class | etallobarbital |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your brain is like a busy city with lots of people talking and moving around. GABA is like a traffic cop that helps to slow down the traffic and keep everything calm. Etallobarbital helps GABA do its job more effectively, which can lead to feelings of relaxation and reduced anxiety.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ethallymal CI brief — competitive landscape report
- Ethallymal updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Ethallymal
What is Ethallymal?
How does Ethallymal work?
What is the generic name of Ethallymal?
What drug class is Ethallymal in?
What development phase is Ethallymal in?
Related
- Drug class: All etallobarbital drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing